High Court finds Sandoz infringed Lundbeck’s Lexapro patent
Angus Lang 2022-03-09 4:40 pm By Miklos Bolza Sydney
Please login to bookmark Close

The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck’s patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au